publication date: Aug. 2, 2019
Trials & Tribulations
Barriers to clinical trial enrollment
Part I of a two-part series
Adedayo A. Onitilo, MD, PhD, MSCR, FACP
Oncology/Hematology and Radiation
Oncology Service Line
Department chair, Oncology/Hematology, Marshfield Clinic
Daniel Wall, BSc
Stephanie Engelien, RN, MSN
Oncology research nurse, Marshfield Clinic
According to the National Cancer Institute (NCI), 1,735,350 people were newly diagnosed with cancer in 2018. Of those, 65% are expected to achieve remission from their cancer 1. While most physicians agree that clinical trials advance medical knowledge and improve treatment, estimates as low as 2 – 3% of cancer patients enter clinical trials annually 2, 3. Physician knowledge of available clinical trials at their site, training in communication skills and administering clinical trials, and time constraints during … Continue reading Barriers to clinical trial enrollment
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.